Aufgrund von Vorbereitungen auf eine neue Version von KOPS, können kommenden Montag und Dienstag keine Publikationen eingereicht werden. (Due to preparations for a new version of KOPS, no publications can be submitted next Monday and Tuesday.)

BAP1 in cancer : epigenetic stability and genome integrity

Cite This

Files in this item

Checksum: MD5:49d655b07020220b263f72f2eb329e00

CAPORALI, Sabrina, Alessio BUTERA, Ivano AMELIO, 2022. BAP1 in cancer : epigenetic stability and genome integrity. In: Discover Oncology. Springer. 13(1), 117. eISSN 2730-6011. Available under: doi: 10.1007/s12672-022-00579-x

@article{Caporali2022-11-01cance-59306, title={BAP1 in cancer : epigenetic stability and genome integrity}, year={2022}, doi={10.1007/s12672-022-00579-x}, number={1}, volume={13}, journal={Discover Oncology}, author={Caporali, Sabrina and Butera, Alessio and Amelio, Ivano}, note={Article Number: 117} }

<rdf:RDF xmlns:dcterms="" xmlns:dc="" xmlns:rdf="" xmlns:bibo="" xmlns:dspace="" xmlns:foaf="" xmlns:void="" xmlns:xsd="" > <rdf:Description rdf:about=""> <dc:creator>Caporali, Sabrina</dc:creator> <dcterms:rights rdf:resource=""/> <dcterms:available rdf:datatype="">2022-11-28T12:21:21Z</dcterms:available> <dcterms:isPartOf rdf:resource=""/> <dc:creator>Amelio, Ivano</dc:creator> <dc:contributor>Caporali, Sabrina</dc:contributor> <dc:rights>Attribution 4.0 International</dc:rights> <dc:contributor>Butera, Alessio</dc:contributor> <bibo:uri rdf:resource=""/> <dcterms:title>BAP1 in cancer : epigenetic stability and genome integrity</dcterms:title> <dcterms:issued>2022-11-01</dcterms:issued> <dspace:hasBitstream rdf:resource=""/> <dc:language>eng</dc:language> <dc:date rdf:datatype="">2022-11-28T12:21:21Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dspace:isPartOfCollection rdf:resource=""/> <dcterms:abstract xml:lang="eng">Mutations in BAP1 have been identified in a hereditary cancer predisposition syndrome and in sporadic tumours. Individuals carrying familiar BAP1 monoallelic mutations display hypersusceptibility to exposure-associated cancers, such as asbestos-driven mesothelioma, thus BAP1 status has been postulated to participate in gene-environment interaction. Intriguingly, BAP1 functions display also a high degree of tissue dependency, associated to a peculiar cancer spectrum and cell types of specific functions. Mechanistically, BAP1 functions as an ubiquitin carboxy-terminal hydrolase (UCH) and controls regulatory ubiquitination of histones as well as degradative ubiquitination of a range of protein substrates. In this article we provide an overview of the most relevant findings on BAP1, underpinning its tissue specific tumour suppressor function. We also discuss the importance of its epigenetic role versus the control of protein stability in the regulation of genomic integrity.</dcterms:abstract> <dc:contributor>Amelio, Ivano</dc:contributor> <dc:creator>Butera, Alessio</dc:creator> <dcterms:hasPart rdf:resource=""/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> </rdf:Description> </rdf:RDF>

Downloads since Nov 28, 2022 (Information about access statistics)

Caporali_2-oj6ztbi7b1w93.pdf 23

This item appears in the following Collection(s)

Attribution 4.0 International Except where otherwise noted, this item's license is described as Attribution 4.0 International

Search KOPS


My Account